1. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy 
Velja Mijatovic, M.D., Ph.D., Sebastiaan Veersema, M.D., Mark Hans Emanuel, M.D., Ph.D., Roel Schats, M.D., Ph.D., Peter G.A. Hompes, M.D., Ph.D. 
Fertility and Sterility 
Volume 93, Issue 4, Pages (March 2010)
DOI: /j.fertnstert
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Hysteroscopic view 3 months after vaginal delivery (patient B): complete tissue encapsulation of the Essure device. The arrow is pointing at the tissue overgrowth at the ostium tubae.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Hysterosalpingogram 3 months after Essure placement (patient D). Two devices are visible with contrast medium in the left hydrosalpinx.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions